Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients
Open accessAbstract
Objective: In breast cancer patients the diagnosis, treatment and aftercare of the physical disease cause a large amount of psychosocial distress, which can have a variety of negative consequences on patients' physical and mental well-being. Although about one-third of the patients show heightened psychosocial distress that may require psychooncological interventions its detection in daily clinical routine is poor and referral to mental health professionals is insufficient. The aim of the study was to develop a short screening tool for the detection of need for psychooncological treatment (POT) in breast cancer patients. Methods: Over a period of six months, 115 breast cancer outpatients attending the Department of Gynaecology at Innsbruck Medical University were consecutively included in the study. Logistic regression analysis and ROC analyses were used to identify the most predictive item set from a set of questionnaires (EORTC-QLQ-C30, HADS and Hornheide Screening Instrument) and other additional questions. Results: Data from 105 breast cancer patients (mean age 58.8, SD 12.3) were available for analysis. A logistic regression equation containing the EORTC-QLQ-C30 scales Emotional Functioning and Role Functioning as well as the yes-no question after psychiatric/ psychological/psychotherapeutic treatment at any point in lifetime showed highest predictive power with regard to need of POT (AUC = 0.88; CI 95% 0.82-0.95). A pilot study (n = 20) investigating applicability of a computerized version of this screening tool in oncological routine showed high acceptance and feasibility. Conclusion: The developed PO-screening tool showed high diagnostic accuracy regarding POT needs. The short assessment time and good usability of its computerized version allowed easy implementation in daily oncological routine. Copyright © 2009 John Wiley & Sons, Ltd.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
4 of 25 cited sources checked · 4 supported · 0 flagged
- Premisecitation
In Soellner et al., for severely distressed patients the sensitivity of oncologists' estimation of distress was 37% and the specificity was 88%.
“For severely distressed patients the sensitivity of oncologists' estimation of distress was 37% and the specificity was 88%.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [16] 16. Soellner W, DeVries A, Steixner E et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001;84(2):179-185. source
- Premisecitation
Physicians may have difficulty identifying patients with a high level of psychosocial distress.
“Furthermore research indicates that physicians may have difficulty identifying patients with a high level of psychosocial distress.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [14] 14. Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84(8):1011-1015. source
- cites [16] 16. Soellner W, DeVries A, Steixner E et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001;84(2):179-185. source
- Findingown data
Stepwise forward-selection showed that the QLQ-C30 subscales Role Functioning and Emotional Functioning as well as PPP-treatment were the optimal predictor set for the need of POT.
“Stepwise forward-selection showed that the QLQ-C30 subscales Role Functioning (RF) and Emotional Functioning (EF) as well as PPPtreatment were the optimal predictor set for the need of POT.”
Quote in the paperSubstantial claim- Rests on an assumption: The clinical rating by psychooncologists based on semistructured interviews is a valid criterion for POT need.
- Findingown data
No significant differences were found for tumour stage between the POT-group and the non-POT-group.
“No significant differences were found for tumour stage.”
Quote in the paperNot a substantial claim - Findingown data
A logistic regression equation containing the EORTC-QLQ-C30 scales Emotional Functioning and Role Functioning as well as the yes-no question after psychiatric/psychological/psychotherapeutic treatment at any point in lifetime showed highest predictive power with regard to need of POT (AUC 0.88; CI 95% 0.82-0.95).
“A logistic regression equation containing the EORTC-QLQ-C30 scales Emotional Functioning and Role Functioning as well as the yes-no question after psychiatric/ psychological/psychotherapeutic treatment at any point in lifetime showed highest predictive power with regard to need of POT (AUC 5 0.88; CI 95% 0.82-0.95).”
- Also stated in: § Multivariate predictor selection · plain
“Stepwise forward-selection showed that the QLQ-C30 subscales Role Functioning (RF) and Emotional Functioning (EF) as well as PPPtreatment were the optimal predictor set for the need of POT.”
- Also stated in: § Multivariate predictor selection · plain
“The AUC for this predictor set was 0.88 (CI95% 0.82-0.95).”
Quote in the paperSubstantial claim- Rests on an assumption: The clinical rating by psychooncologists based on semistructured interviews is a valid criterion for POT need.
- Also stated in: § Multivariate predictor selection · plain
- Findingown data
The QLQ-C30 Nausea/Vomiting and Cognitive Functioning scales showed the lowest predictive power.
“The QLQ-C30 Nausea/Vomiting and the Cognitive Functioning scales showed the lowest predictive power.”
Quote in the paperNot a substantial claim - Findingown data
The EORTC-QLQ-C30 Emotional Functioning scale shows the highest prognostic value regarding the need for POT.
“The finding that the EORTC-QLQ-C30 scale Emotional Functioning shows the highest prognostic value regarding the need for POT was not surprising since it covers aspects of anxiety as well as of depression.”
- Also stated in: § Discussion · plain
“QLQ-C30 Emotional Functioning | 0.81 | 0.72-0.90”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
The PO-screening tool is highly discriminative between patients requiring and not requiring POT, with an AUC of 0.88.
“This resulted in a PO-screening tool that was highly discriminative between patients requiring or not requiring POT (AUC 5 0.88).”
- Also stated in: § Discussion · plain
“In summary, the screening tool developed in this study showed high diagnostic accuracy regarding the need for POT in breast cancer outpatients.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
The assessment time of the PO-screening tool is 2.8 min.
“Furthermore assessment time (2.8 min) is very short, facilitating implementation into the clinical routine.”
Quote in the paperSubstantial claim - Findingown data
A pilot study with 20 patients investigating applicability of a computerized version of the screening tool in oncological routine showed high acceptance and feasibility.
“A pilot study (n 5 20) investigating applicability of a computerized version of this screening tool in oncological routine showed high acceptance and feasibility.”
Quote in the paperSubstantial claim - Findingown data
The average time for assessment was 2.8 min (SD 1.1).
“The average time for assessment was 2.8 min (SD 1.1).”
Quote in the paperNot a substantial claim - Findingown data
The weighted combination of scales assessing different aspects of psychosocial impairment raises diagnostic accuracy substantially.
“The weighted combination of scales assessing different aspects of psychosocial impairment raises diagnostic accuracy substantially (sensitivities and specificities, e.g.0.79/0.79and 0.71/0.85).”
Quote in the paperSubstantial claim - Findingown data
The most predictive single scale only reached an AUC of 0.81 (QLQ-C30 Emotional Functioning).
“since the most predictive single scale only reached an AUC of 0.81 (QLQ-C30 Emotional Functioning).”
Quote in the paperSubstantial claim - Findingown data
PPP-treatment differed significantly between the POT and non-POT groups (p<0.001).
“PPP-treatment | | | | | | w 2 5 17.90; p 5 o0.001”
Quote in the paperSubstantial claim - Findingown data
The sample consisted only of breast cancer outpatients.
“A limitation or rather a specialization of the screening tool is the fact that the sample consisted only of breast cancer outpatients.”
Quote in the paperSubstantial claim - Findingown data
QLQ-C30 Emotional Functioning had a univariate AUC of 0.81 (95% CI 0.72-0.90).
“QLQ-C30 Emotional Functioning | 0.81 | 0.72-0.90”
Quote in the paperSubstantial claim - Interpretationown data
The weighted combination of Role Functioning, Emotional Functioning and PPP-treatment results in a relevant improvement of diagnostic accuracy compared with single subscales.
“The weighted combination of RF, EF and PPPtreatment therefore results in a relevant improvement of diagnostic accuracy compared with single subscales.”
Quote in the paperSubstantial claim- Rests on an assumption: The clinical rating by psychooncologists based on semistructured interviews is a valid criterion for POT need.
- Premisecitation
Patients with psychosocial distress show poorer satisfaction with care.
“poorer satisfaction with care [4]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] 4. Holland JC. Update: NCCN practice guidelines for the management of psychosocial distress. Oncology 1999;13(11A):459-507.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
The short assessment time of the PO-screening tool facilitates its implementation into clinical routine.
“Furthermore assessment time (2.8 min) is very short, facilitating implementation into the clinical routine.”
Quote in the paperSubstantial claim - Premisecitation
Patients with psychosocial distress show diminished adaptation to life with the disease.
“diminished adaptation to life with the disease [5]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] 5. Von Essen L, Larsson G, Oberg K, Sjoden PO. 'Satisfaction with care': associations with health-related quality of life and psychosocial function among Swedish patients with endocrine gastrointestinal tumours. Eur J Cancer Care (Engl) 2002;11(2):91-99. source
- Premisecitation
Patients with psychosocial distress show greater nonadherence to treatment recommendations.
“As a consequence, patients with psychosocial distress show greater nonadherence to treatment recommendations [3]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] 3. Kennard BD, Stewart SM, Olvera R et al. Nonadher- ence in adolescent oncology patients: preliminary data on psychological risk factors and relationships to outcome. J Clin Psychol Med Settings 2004;11(1):31-39. source
- Premisecitation
Patients with psychosocial distress show poorer quality of life across multiple domains.
“poorer quality of life (QOL) across multiple domains [6]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] 6. Skarstein J, Aass N, Fossa SD, Skovlund E, Dahl AA. Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res 2000;49(1):27-34. source
- Premisecitation
The QLQ-C30 Emotional Functioning scale is strongly related to anxiety, depression or general distress.
“Subscales like the QLQ-C30 Emotional Functioning scale are for example strongly related to anxiety, depression or general distress [6].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] 6. Skarstein J, Aass N, Fossa SD, Skovlund E, Dahl AA. Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res 2000;49(1):27-34. source
- Premisecitation
Unrecognized and untreated psychosocial distress may increase treatment costs.
“Moreover, unrecognized and untreated psychosocial distress may also increase treatment costs, which is of great importance in the context of competing demands for resources within contemporary healthcare systems.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [8] 8. Rosenberg HJ, Rosenberg SD, Ernstoff MS et al. Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med 2002;32(1): 37-53. source
- cites [9] 9. Simpson JS, Carlson LE, Trew ME. Effect of group therapy for breast cancer on healthcare utilization. Cancer Pract 2001;9(1):19-26. source
- Interpretationown data
The short assessment time and good usability of the computerized version of the PO-screening tool allowed easy implementation in daily oncological routine.
“The short assessment time and good usability of its computerized version allowed easy implementation in daily oncological routine.”
Quote in the paperSubstantial claim- Rests on an assumption: Short screening instruments require less resources and especially less time than training oncologists.
- Interpretationown data
The developed PO-screening tool showed high diagnostic accuracy regarding POT needs.
“The developed PO-screening tool showed high diagnostic accuracy regarding POT needs.”
Quote in the paperSubstantial claim- Rests on an assumption: The clinical rating by psychooncologists based on semistructured interviews is a valid criterion for POT need.
- Premisecitation
Undetected psychosocial distress in oncological patients can contribute to the development of chronic mental disorders.
“In addition if psychosocial distress in oncological patients stays undetected it can also contribute to the development of chronic mental disorders [7].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] 7. Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry 2004;38(5):320-326. source
- Study design and conductown data
The Hosmer-Lemeshow test showed a good fit of the regression model (Chi2=7.52, df=8, p=0.48).
“The Hosmer-Lemeshow-test showed a good fit of this regression model (Chi2 5 7.52, df 5 8, p 5 0.48).”
Quote in the paperNot a substantial claim - Interpretationreasoning
The logistic regression equation described is specific for breast cancer patients.
“It can be expected that the optimal combination of scales and items differs, e.g.across tumour types and course of treatment and disease, therefore the logistic regression equation described is presumed to be specific for breast cancer patients.”
Quote in the paperSubstantial claim - Interpretationreasoning
Screening for the need for POT can be easily integrated in PRO monitoring because the EORTC-QLQ-C30 is widely used.
“Since the EORTC-QLQ-C30 is widely used in the assessment of PROs in oncological research and increasingly in oncological care, screening for the need for POT can be easily integrated in PRO monitoring offering very important extra information.”
Quote in the paperSubstantial claim- Rests on an assumption: The EORTC-QLQ-C30 is widely used in the assessment of PROs in oncological research and increasingly in oncological care.
- May combine two claims. 23
- Classified as probably not a substantial claim. 25
May combine two claims.
PremisecitationIn Fallowfield et al., for 36% of patients the GHQ-12 suggested psychiatric morbidity; sensitivity of physicians' ratings was 29% and specificity was 85%.
“For 36% of the patients, the GHQ-12 suggested psychiatric morbidity.Sensitivity of the physicians' ratings was 29%, specificity was 85%.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [14] 14. Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84(8):1011-1015. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataIn the screening pilot, 8 patients were allocated to the POT-group and 12 patients to the Non-POT-group using a cut-off score of 0.30.
“Owing to the screening results 8 patients were allocated to the POT-group and 12 patients to the Non-POT-group (cut-off score 5 0.30).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningThe Role Functioning scale consists of two items and adds valuable information by addressing impairment in daily work and leisure activities.
“The Role Functioning scale, consisting of two items, adds valuable information since it addresses a quite different aspect, namely impairment in daily work and leisure activities.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataNone of the questions were omitted.
“None of the questions were omitted.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBest single predictions were derived from the QLQ-C30 Emotional Functioning and Social Functioning scales and from both HADS scales, but predictive power of these single scales was only moderate.
“Best single predictions were derived from the QLQ-C30 Emotional Functioning and Social Functioning scales and from both HADSscales, but predictive power of these single scales was only moderate.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAssistance in filling in the questionnaire on the touchscreen of a tablet-PC was not needed.
“Assistance in filling in the questionnaire on the touchscreen of a tablet-PC (Figure 2(a)) was not needed.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe PO-screening tool achieved sensitivities and specificities of 0.79/0.79 and 0.71/0.85 at certain cut-offs.
“0.79 | 0.79 | 66.0% | 0.30”
- Also stated in: § Discussion · plain
“0.71 | 0.85 | 71.4% | 0.46”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTwo patients required information regarding the content of certain items.
“Two of the patients required information regarding the content of certain items.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe computerized screening tool implemented in CHES revealed no problems regarding usability and proved good acceptance.
“As a result of the semi-structured interviews, the computerized screening tool implemented in CHES revealed no problems regarding usability and proved good acceptance.”
Quote in the paperSubstantial claim- Rests on an assumption: Short screening instruments require less resources and especially less time than training oncologists.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataUsing stepwise backward-elimination as the selection procedure yielded very similar results.
“Using stepwise backward-elimination as selection procedure yielded very similar results (not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll employed scales were able to discriminate between the POT-group and the non-POT-group, with the POT-group having significantly poorer QOL and functioning scores and significantly higher impairment and symptom scores than the non-POT-group.
“ROC-analyses showed that all employed scales were able to discriminate between the POT-group and the non-POT-group with the POT-group having significantly poorer QOL and functioning scores and significantly higher impairment and symptom scores than the non-POT-group.”
Quote in the paperSubstantial claim- Rests on an assumption: The clinical rating by psychooncologists based on semistructured interviews is a valid criterion for POT need.
May combine two claims.
Findingown dataEmployment status and PPP-treatment differed significantly between the POT-group and the non-POT-group.
“Furthermore employment status and PPP-treatment differed significantly between these two groups.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningThe PO-screening tool overlaps with the EORTC-QLQ-C30 and requires only one question (regarding PPP-treatment) to be added.
“A further advantage of the PO-screening tool developed in this study is that it overlaps with the EORTC-QLQ-C30 and requires only one question (regarding PPP-treatment) to be added.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationComputer-based testing is highly feasible in a clinical setting and well accepted by patients.
“Our pilot study and other trials [47,48] indicate that computer-based testing is highly feasible in a clinical setting and well accepted by the patients.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [47] 47. Carlson LE, Speca M, Hagen N, Taenzer P. Computer- ized quality-of-life screening in a cancer pain clinic. J Palliat Care 2001;17(1):46-52. source
- cites [48] 48. Taenzer PA, Speca M, Atkinson MJ et al. Computer- ized quality-of-life screening in an oncology clinic. Cancer Pract 1997;5(3):168-175.
Classified as probably not a substantial claim. May combine two claims.
FindingreasoningThe PPP-treatment item records lifetime information and does not only measure present condition.
“In contrast to the two other scales it records lifetime information and does not only measure present condition.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Computer-based Health Evaluation System (CHES) showed high applicability in the screening pilot and good acceptance by patients and medical staff.
“Our specially developed Computer-based Health Evaluation System (CHES) showed high applicability in the conducted screening pilot and good acceptance by patients and medical staff.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn logistic regression, PPP-treatment, QLQ-C30 Role Functioning, and QLQ-C30 Emotional Functioning were significant predictors of POT need.
“PPP-treatment | 2.1578 | 0.613 | 12.410 | 1 | 0.000 | 8.652”
- Also stated in: § Discussion · plain
“QLQ-C30 Role Functioning | À0.0232 | 0.010 | 5.604 | 1 | 0.018 | 0.977”
- Also stated in: § Discussion · plain
“QLQ-C30 Emotional Functioning | À0.0387 | 0.013 | 8.260 | 1 | 0.004 | 0.962”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn the sample, 34.3% of patients were in the POT group.
“69 (65.7%) | | 36 (34.3%) | | 105 (100.0%)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataOwing to missing test scores in some scales, only 88 patients could be used for the selection procedure.
“Owing to missing test scores in some scales only 88 patients could be used for the selection procedure.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAbout 25-40% of breast cancer patients experience psychological problems and psychosocial distress related to the disease and its treatment.
“Patients diagnosed with breast cancer are confronted with a wide range of stressors related to the disease and its treatment and this results in psychological problems and psychosocial distress in about 25-40% of breast cancer patients [1,2].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] 1. Coyne JC, Palmer SC, Shapiro PJ, Thompson R, DeMichele A. Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry 2004;26(2):121-128. source
- cites [2] 2. Hegel MT, Moore CP, Collins ED et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 2006;107(12):2924-2931. source
May combine two claims.
PremisecitationIdentification of highly distressed patients is often insufficient in clinical oncology settings and the rate of referral to mental health professionals is low.
“Despite the fact that many patients suffer from high distress, identification of those is often insufficient in clinical oncology settings and the rate of referral to mental health professionals is low [12,13].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] 12. Carlson LE, Bultz BD. Cancer distress screening. Needs, models, and methods. J Psychosom Res 2003; 55(5):403-409. source
- cites [13] 13. Newport DJ, Nemeroff CB. Assessment and treatment of depression in the cancer patient. J Psychosom Res 1998;45(3):215-237. source
- Rests on an assumption: Physicians are often too pressed for time to adequately inquire about patients' psychological status, and patients do not spontaneously talk about their distress.
May combine two claims.
PremisecitationExisting scales can discriminate to some extent between patients in need of POT and patients not in need, but diagnostic accuracy is only moderate and there is no agreement on the most appropriate screening instrument.
“Research evaluating these scales has shown that all of them are able to discriminate to some extent between patients who are in need of POT and patients who are not.However, diagnostic accuracy is only moderate and there is no agreement on which is the most appropriate screening instrument.”
Quote in the paperSubstantial claim- Rests on an assumption: General classification schemes like the DSM-IV or the ICD-10 are not fully appropriate to assess the whole range of aspects relevant to the need of POT, and symptoms presented by oncological patients may not be classifiable with reference to mental disorders.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe HSI has been developed as a screening tool for POT needs in facial and skin cancer patients.
“The HSI has been developed as a screening tool for POT needs in facial and skin cancer patients.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] 40. Strittmatter G, Tilkorn M, Mawick R. How to identify patients in need of psychological intervention. Recent results. Cancer Res 2002;160:353-361. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe high prevalence of psychosocial impairments in breast cancer patients is well documented in the literature.
“The high prevalence of psychosocial impairments in breast cancer patients is well documented in the literature [42].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] 42. Mehnert A, Koch U. Prevalence of acute and post- traumatic stress disorder and comorbid mental dis- orders in breast cancer patients during primary cancer care: a prospective study. Psycho-Oncology 2007;16(3):181-188. source
Classified as probably not a substantial claim.
Study design and conductnone givenThe psychooncologists were blinded to all variables used for the development of the screening tool.
“The psychooncologists were blinded to all variables used for the development of the screening tool (although demographic and clinical issues could of course be explored in the interview).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe clinical rating of POT need was based on extensive semistructured patient interviews conducted by two experienced psychooncologists.
“In a second stage of the assessment two experienced psychooncologists rated the patients as positive or negative cases depending on whether or not they were assessed as being in need of POT.This clinical rating was based on extensive semistructured patient interviews.”
Quote in the paperSubstantial claim- Rests on an assumption: The clinical rating by psychooncologists based on semistructured interviews is a valid criterion for POT need.
- Rests on an assumption: The semistructured interview schedule compiled by five experts covers the relevant issues for POT need.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe EORTC-QLQ-C30 is an internationally validated and widely used cancer-specific QOL instrument that assesses various facets of functioning, symptoms common in cancer patients and general QOL.
“The EORTC-QLQ-C30, an internationally validated and widely used cancer-specific QOL-instrument, assesses various facets of functioning, symptoms common in cancer patients and general QOL.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] 30. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365-376. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe HADS is one of the most common screening tools for anxiety and depression in clinical studies and has been developed for use in the physically ill.
“The HADS is one of the most common screening tools for anxiety and depression in clinical studies and has been developed for use in the physically ill.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] 17. Zigmond A, Snaith R. The hospital anxiety and depres- sion scale. Acta Psychiatr Scand 1983;67(6):361-370. source
May combine two claims.
PremisecitationIn the HSI pilot study, 85.7% of grouped cases were correctly classified and Cronbach's alpha for the HSI was 0.62.
“In this pilot study 85.7% of grouped cases were correctly classified.Cronbachs alpha for the HSI was 0.62 [40].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] 40. Strittmatter G, Tilkorn M, Mawick R. How to identify patients in need of psychological intervention. Recent results. Cancer Res 2002;160:353-361. source
May combine two claims.
PremisecitationThe EORTC-QLQ-C30 Emotional Functioning scale is composed of only four items and is significantly shorter than the HADS subscales, GHQ-12, and K10 scale.
“The EORTC-QLQ-C30 scale Emotional Functioning also has the advantage of being composed of only four items and is therefore significantly shorter than other fairly brief scales like the HADS subscales (each seven items), the GHQ-12 [45] or the K10 scale [46].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [45] 45. Goldberg DP, Gater R, Sartorius N et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997;27(1):191-197. source
- cites [46] 46. Kessler RC, Andrews G, Colpe LJ et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med 2002;32(6):959-976. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataOf 115 breast cancer patients approached, 105 were available for analysis after 10 were excluded because rating of POT-need was not possible due to time constraints.
“All of the 115 patients approached as potential study participants met the inclusion criteria and signed informed consent, but 10 had to be excluded from analyses because rating of POT-need was not possible due to time constraints.Sociodemographic and clinical data for the remaining 105 patients are shown in Table 1.”
- Also stated in: § Abstract · plain
“Data from 105 breast cancer patients (mean age 58.8, SD 12.3) were available for analysis.”
Quote in the paperNot a substantial claim- Also stated in: § Abstract · plain
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningSpecification of a cut-off score is a matter of balancing heightened resource use due to false-positive patients with the problem of neglecting patients with severe psychosocial impairments.
“Therefore, the specification of a certain cut-off score is a matter of balancing heightened use of resources due to false-positive patients with the problem of neglecting patients suffering from severe psychosocial impairments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
InterpretationreasoningScreening tools are of greater importance in outpatients than in inpatients because contact between patient and medical staff is less intensive in outpatients.
“However, screening tools are of greater importance in outpatients than in inpatients since contact between patient and medical staff is much less intensive in outpatients.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenThe sample size in the study was rather limited.
“Moreover, further validity testing of the screening tool is needed, since the sample size in our study was rather limited.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
InterpretationreasoningThe time and effort required to implement the tool into oncological routine can be reduced significantly by using a computerized version, which is well accepted by patients and offers real-time results.
“The time and effort required to implement the tool into oncological routine can be reduced significantly by using a computerized version, which is well accepted by patients and offers real-time results.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe proposed screening tool requires access to adequate hardware and software resources.
“Clearly, the proposed screening tool requires access to adequate hardware and software resources.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenThe single item assessing former PPP-treatment may reflect a general psychological vulnerability and/or the impact of stressful life events prior to disease onset.
“The single item assessing former PPP-treatment may reflect a general psychological vulnerability and/or the impact of stressful life events prior to disease onset.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningThe higher the cut-off score, the more likely a patient scoring above is really in need of POT, but the proportion of undetected patients in need of POT increases.
“The higher the cut-off score, the more likely a patient scoring above is really in need of POT.But at the same time the proportion of undetected patients being in need of POT increases.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningComputer-based testing provides real-time availability of screening results.
“Another major advantage of computer-based testing is the real-time availability of the screening results, which is of great importance in the context of the short patient contacts common in outpatient units.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningThe cut-off score can be adjusted to available POT capacities in daily oncological practice.
“In the context of implementation into daily oncological practice the cut-offs core can be adjusted to available POT capacities.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe optimal combination of scales and items differs across tumour types and course of treatment and disease.
“It can be expected that the optimal combination of scales and items differs, e.g.across tumour types and course of treatment and disease, therefore the logistic regression equation described is presumed to be specific for breast cancer patients.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
General classification schemes like the DSM-IV or the ICD-10 are not fully appropriate to assess the whole range of aspects relevant to the need of POT, and symptoms presented by oncological patients may not be classifiable with reference to mental disorders.
“Unfortunately, general classification schemes like the DSM-IV or the ICD-10 are not fully appropriate to assess the whole range of aspects relevant to the need of POT and symptoms presented by oncological patients may not be classifiable with reference to mental disorders.”
The paper relies on this without support.
Physicians are often too pressed for time to adequately inquire about patients' psychological status, and patients do not spontaneously talk about their distress.
“Usually the workload of the staff in a routine clinical setting is high.Physicians are often too pressed for time to adequately inquire about patients' psychological status and patients, already struggling with the stigma of a cancer diagnosis, do not spontaneously talk about their distress.”
The paper relies on this without support.
Short screening instruments require less resources and especially less time than training oncologists.
“The latter has the obvious advantage of requiring less resources and especially less time.”
The paper relies on this without support.
The clinical rating by psychooncologists based on semistructured interviews is a valid criterion for POT need.
“In a second stage of the assessment two experienced psychooncologists rated the patients as positive or negative cases depending on whether or not they were assessed as being in need of POT.This clinical rating was based on extensive semistructured patient interviews.”
The paper relies on this without support.
The semistructured interview schedule compiled by five experts covers the relevant issues for POT need.
“The interview schedule was compiled in a panel of five experts in the field of psychooncology.It comprised the following issues: current treatment situation, physical and psychosocial symptom burden, medical and psychosocial history, coping strategies, social resources, social problems and future perspective.”
The paper relies on this without support.
Improvement in detection rates of patients with high psychosocial distress depends heavily on the use of appropriate screening instruments.
“An improvement in detection rates of patients suffering from high psychosocial distress is heavily dependent on the use of appropriate screening instruments, such as the PO-screening tool presented in this study.”
The paper relies on this without support.
The lack of screening instruments with satisfying sensitivities and perceived barriers to implementation result in insufficient use of such instruments and neglect of patients in need of POT.
“The lack of screening instruments with satisfying sensitivities with regard to POT need and perceived barriers towards implementation of screening into oncological routine still result in an insufficient use of such instruments and consequently in a neglect of patients being in need of POT.”
The paper relies on this without support.
The EORTC-QLQ-C30 is widely used in the assessment of PROs in oncological research and increasingly in oncological care.
“Since the EORTC-QLQ-C30 is widely used in the assessment of PROs in oncological research and increasingly in oncological care, screening for the need for POT can be easily integrated in PRO monitoring offering very important extra information.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Overall mean age exceeds both group means
MinorThe reported overall mean age is 58.8 years, although the two groups' means are 58.1 and 57.3 years. An overall mean cannot exceed both group means.
“Data from 105 breast cancer patients (mean age 58.8, SD 12.3) were available for analysis.”
“| Age (years) | Mean (SD) | 58.1 (12.7) | | 57.3 (11.6) | | 58.8 (12.3) t 5 0.31; p 5 0.759 |”
Percentage for patients without prior PPP-treatment is incorrect
MinorThe table gives 74 patients without prior PPP-treatment out of 105 patients, which is 70.5%, not 71.8%.
Reported 71.8 · recomputed 70.47619
“| No | 58 | (84.1%) | 16 | (44.4%) | 74 | (71.8%) |”
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · see citing works
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005 · see citing works
KESSLER, R. C., ANDREWS, G., COLPE, L. J., HIRIPI, E., MROCZEK, D. K., NORMAND, S.-L. T., WALTERS, E. E., & ZASLAVSKY, A. M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006074 · Cited by 10,327 · see citing works
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · see citing works
(1988) · NFER-Nelson eBooks · Cited by 5,560 · see citing works
The Validity of Two Versions of the GHQ in the WHO Study of Mental Illness in General Health Care
GOLDBERG, D. P., GATER, R., SARTORIUS, N., USTUN, T. B., PICCINELLI, M., GUREJE, O., & RUTTER, C. (1997) · Psychological Medicine · doi:10.1017/s0033291796004242 · Cited by 3,657 · see citing works
Book Review: Measurement and Classification of Psychiatric Symptoms
Priest, R. G. (1975) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577506800751 · Cited by 2,268 · see citing works
Measurement and classification of psychiatric symptoms
Goldberg, D. P. (1975) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(75)90076-8 · Cited by 2,194 · see citing works
Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.078 · Cited by 1,382 · see citing works
Detmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002) · JAMA · doi:10.1001/jama.288.23.3027 · Cited by 1,011 · see citing works
High levels of untreated distress and fatigue in cancer patients
Carlson, L. E., Angen, M., Cullum, J., Goodey, E., Koopmans, J., Lamont, L., MacRae, J. H., Martin, M., Pelletier, G., Robinson, J., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601887 · Cited by 939 · see citing works
Screening for psychologic distress in ambulatory cancer patients
Jacobsen, P. B., Donovan, K. A., Trask, P. C., Fleishman, S. B., Zabora, J. R., Baker, F., & Holland, J. C. (2005) · Cancer · doi:10.1002/cncr.20940 · Cited by 827 · see citing works
Psychiatric morbidity and its recognition by doctors in patients with cancer
Fallowfield, L., Ratcliffe, D., Jenkins, V, & Saul, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1724 · Cited by 694 · see citing works
Söllner, W., DeVries, A., Steixner, E., Lukas, P., Sprinzl, G., Rumpold, G., & Maislinger, S. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1545 · Cited by 442 · see citing works
Self-citationMehnert, A., & Koch, U. (2007) · Psycho-Oncology · doi:10.1002/pon.1057 · Cited by 402 · see citing works
Carlson, L. E., & Bultz, B. D. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00514-2 · Cited by 351 · see citing works
Velikova, G., Wright, E. P., Smith, A. B., Cull, A., Gould, A., Forman, D., Perren, T., Stead, M., Brown, J., & Selby, P. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.998 · Cited by 339 · see citing works
Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis
Kissane, D. W., Grabsch, B., Love, A., Clarke, D. M., Bloch, S., & Smith, G. C. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01358.x · Cited by 337 · see citing works
Skarstein, J., Aass, N., Fosså, S. D., Skovlund, E., & Dahl, A. A. (2000) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(00)00080-5 · Cited by 301 · see citing works
Hegel, M. T., Moore, C. P., Collins, E. D., Kearing, S., Gillock, K. L., Riggs, R. L., Clay, K. F., & Ahles, T. A. (2006) · Cancer · doi:10.1002/cncr.22335 · Cited by 296 · see citing works
Kennard, B. D., Stewart, S. M., Olvera, R., Bawdon, R. E., hAilin, A. O., Lewis, C. P., & Winick, N. J. (2004) · Journal of Clinical Psychology in Medical Settings · doi:10.1023/b:jocs.0000016267.21912.74 · Cited by 190 · see citing works
Expressive Disclosure and Health Outcomes in a Prostate Cancer Population
Rosenberg, H. J., Rosenberg, S. D., Ernstoff, M. S., Wolford, G. L., Amdur, R. J., Elshamy, M. R., Bauer-Wu, S. M., Ahles, T. A., & Pennebaker, J. W. (2002) · The International Journal of Psychiatry in Medicine · doi:10.2190/agpf-vb1g-u82e-ae8c · Cited by 179 · see citing works
Shim, E., Shin, Y., Jeon, H. J., & Hahm, B. (2008) · Psycho-Oncology · doi:10.1002/pon.1275 · Cited by 177 · see citing works
Hall, A., A’Hern, R., & Fallowfield, L. J. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00308-6 · Cited by 177 · see citing works
ESSEN, L. V., LARSSON, G., ÖBERG, K., & SJÖDÉN, P. O. (2002) · European Journal of Cancer Care · doi:10.1046/j.1365-2354.2002.00293.x · Cited by 176 · see citing works
Assessment and treatment of depression in the cancer patient
Newport, D. J., & Nemeroff, C. B. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(98)00011-7 · Cited by 167 · see citing works
Effect of Group Therapy for Breast Cancer on Healthcare Utilization
Simpson, J. S. A., Carlson, L. E., & Trew, M. E. (2001) · Cancer Practice · doi:10.1046/j.1523-5394.2001.91005.x · Cited by 147 · see citing works
Effect of Group Therapy for Breast Cancer on Healthcare Utilization
Simpson, J. S. A., Carlson, L. E., & Trew, M. E. (2001) · Cancer Practice · doi:10.1111/j.1523-5394.2001.91005.pp.x · Cited by 147 · see citing works
Coyne, J. C., Palmer, S. C., Shapiro, P. J., Thompson, R., & DeMichele, A. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2003.08.012 · Cited by 123 · see citing works
Feasibility and Compliance of Automated Measurement of Quality of Life in Oncology Practice
Wright, E. P., Selby, P. J., Crawford, M., Gillibrand, A., Johnston, C., Perren, T. J., Rush, R., Smith, A., Velikova, G., Watson, K., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.044 · Cited by 119 · see citing works
(1997) · PubMed · Cited by 100 · see citing works
Love, A. W., Grabsch, B. E., Clarke, D. M., Bloch, S., & Kissane, D. W. (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01385.x · Cited by 100 · see citing works
Computerized Quality-of-Life Screening in a Cancer Pain Clinic
Carlson, L. E., Speca, M., Hagen, N., & Taenzer, P. (2001) · Journal of Palliative Care · doi:10.1177/082585970101700108 · Cited by 89 · see citing works
Cull, A., Gould, A., House, A., Smith, A., Strong, V, Velikova, G., Wright, P., & Selby, P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2182 · Cited by 73 · see citing works
Are Touchscreen Computer Surveys Acceptable to Medical Oncology Patients?
Newell, S., Girgis, A., Sanson-Fisher, R. W., & Stewart, J. (1997) · Journal of Psychosocial Oncology · doi:10.1300/j077v15n02_03 · Cited by 57 · see citing works
Recklitis, C. J., Licht, I., Ford, J. S., Oeffinger, K. C., & Diller, L. (2007) · Psycho-Oncology · doi:10.1002/pon.1212 · Cited by 53 · see citing works
Rumpold, G., Augustin, M., Zschocke, I., Strittmatter, G., & Söllner, W. (2001) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/s-2001-10028 · Cited by 40 · see citing works
Self-citationHow to Identify Patients in Need of Psychological Intervention
Strittmatter, G., Tilkorn, M., & Mawick, R. (2002) · Recent Results in Cancer Research · doi:10.1007/978-3-642-59410-6_40 · Cited by 40 · see citing works
de Vries, A., Söllner, W., Steixner, E., Auer, V., Schiessling, G., Stzankay, A., Iglseder, W., & Lukas, P. H. (1998) · Strahlentherapie und Onkologie · doi:10.1007/bf03038562 · Cited by 36 · see citing works
Prädiktoren psychischer Störungen bei Tumorpatienten: Empirische Befunde
Krauß, O., Ernst, J., Kuchenbecker, D., Hinz, A., & Schwarz, R. (2007) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/s-2006-952034 · Cited by 36 · see citing works
Psychosozialer Betreuungsbedarf bei stationären Tumorpatienten
Goerling, U., Odebrecht, S., Schiller, G., & Schlag, P. M. (2005) · Der Chirurg · doi:10.1007/s00104-005-1094-y · Cited by 27 · see citing works
Sehlen, S., Fahmüller, H., Herschbach, P., Aydemir, U., Lenk, M., & Dühmke, E. (2003) · Strahlentherapie und Onkologie · doi:10.1007/s00066-003-1057-5 · Cited by 17 · see citing works
(1998) · PubMed · Cited by 14 · see citing works
Goerling, U., Odebrecht, S., Schiller, G., et al. (2006) · Cited by 2 · see citing works
Rapid screening for psychologic distress in men with prostate carcinoma
Roth, A. J., Kornblith, A. B., Batel-Copel, L., Peabody, E., Scher, H. I., & Holland, J. C. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10
The prevalence of psychological distress by cancer site
Zabora, J., BrintzenhofeSzoc, K., Curbow, B., Hooker, C., & Piantadosi, S. (2001) · Psycho-Oncology · doi:10.1002/1099-1611(200101/02)10:1
Flagged first, then by citations
2 of the 49 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Holland JC, 1999, Update: NCCN practice guidelines for the management of psychosocial distress, Oncology, 13, 459
- DeVries A, 1998, Psychosocial distress and need for supportive counselling in patients during radiotherapy, Strahlenther Onkol, 174, 408
- Derogatis LR, 1993, BSI Brief Symptom Inventory: Administration, Scoring and Procedures Manual
- Derogatis LR, 1983, SCL‐90‐R Revised Manual
- Holzner B, 2004, Computerized assessment of quality of life in patients undergoing chemotherapy, Qual Life Res, 13, 1523
Cited by
Sorted by citations
Comprehensive needs assessment tool in cancer (CNAT): the development and validation
Shim, E., Lee, K., Park, J. H., & Park, J. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-1037-0 · Cited by 78 · see citing works
“While the majority of existing tools have focused on specific topics[ 24 , 25] or on needs of specific target populations in terms of disease trajectory and ethnicity [19, 20, 26], the CNAT, within the time frame of 1 month, comprehensively evaluated a wide range of needs generic to all cancer patients throughout thei…”
BackgroundMeraner, V., Gamper, E., Grahmann, A. V., Giesinger, J. M., Wiesbauer, P., Sztankay, M. J., Zeimet, A. G., Sperner‐Unterweger, B., & Holzner, B. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-77 · Cited by 67 · see citing works
“2Rosenegg 48a, A-6391 Fieberbrunn, Austria.”
BackgroundInfluentialSelf-citationFox, J. P., Philip, E. J., Gross, C. P., Desai, R. A., Killelea, B. K., & Desai, M. M. (2013) · The Breast Journal · doi:10.1111/tbj.12096 · Cited by 65 · see citing works
“Many screening tools have been developed to aid this effort (30), although regular use is variable.”
BackgroundGenerating event logs from non-process-aware systems enabling business process mining
Pérez‐Castillo, R., Weber, B., Pinggera, J., et al. (2011) · Enterprise Information Systems · doi:10.1080/17517575.2011.587545 · Cited by 61 · see citing works
Self-citationSchäffeler, N., Pfeiffer, K., Ringwald, J., Brucker, S. Y., Wallwiener, M., Zipfel, S., & Teufel, M. (2015) · Psycho-Oncology · doi:10.1002/pon.3855 · Cited by 59 · see citing works
“[28], we used the subscales ‘role functioning’ and ‘emotional functioning’ of the Quality-of-LifeQuestionnaire EORTC-QLQ-C30 [39].”
BackgroundMethodEijzenga, W., Bleiker, E. M. A., Hahn, D. E. E., Kluijt, I., Sidharta, G. N., Gundy, C. M., & Aaronson, N. K. (2014) · Psycho-Oncology · doi:10.1002/pon.3485 · Cited by 57 · see citing works
“This is in line with development procedures of other screening tools [25].”
ResultHarrison, J. D., Young, J. M., Solomon, M. J., Butow, P. N., Secomb, R., & Masya, L. M. (2011) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e31820bc152 · Cited by 51 · see citing works
“8 Sex Male 22 (58) 23 (64) Female 16 (42) 13 (36) Marital status Married/with partner 25 (65) 19 (53) Not married 14 (37) 17 (47) Country of birth Australia 29 (76) 22 (61) Other 9 (24) 14 (39) Language English 32 (84) 29 (81) Other 6 (16) 7 (19) Financial class Public 16 (42) 24 (67) Private 22 (58 12 (33) Admission…”
Aktuelle Versorgungsstrukturen in der Psychoonkologie
Singer, S., Wickert, M., Weis, J., & Heckl, U. (2011) · Nervenheilkunde · doi:10.1055/s-0038-1627780 · Cited by 27 · see citing works
“Um die Belastung für die Patienten durch das Ausfüllen von Fragebögen so gering wie möglich zu halten und dabei trotzdem zu möglichst präzisen Einschätzungen ihres Befindens zu kommen, werden in letzter Zeit verstärkt computeradaptive Tests entwickelt, bei denen die jeweils nächste Frage vom Antwortverhalten der vorhe…”
BackgroundGraf, J., Simoes, E., Wisslicen, K., Rava, L., Walter, C. B., Hartkopf, A. D., Keilmann, L., Taran, A., Wallwiener, S., Fasching, P. A., et al. (2016) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0042-105872 · Cited by 24 · see citing works
Tabu Search and Machine‐Learning Classification of Benign and Malignant Proliferative Breast Lesions
Dhahri, H., Rahmany, I., Mahmood, A., Maghayreh, E. A., & Elkilani, W. S. (2020) · BioMed Research International · doi:10.1155/2020/4671349 · Cited by 25 · see citing works
“There have been many breast cancer diagnosis methods that were used to increase diagnostic accuracy [3, 4].”
MethodGiesinger, J. M., Kemmler, G., Meraner, V., Gamper, E., Oberguggenberger, A., Sperner‐Unterweger, B., & Holzner, B. (2009) · Breast Care · doi:10.1159/000224158 · Cited by 20 · see citing works
Self-citationThe need for psycho-oncological support for melanoma patients
Mayer, S., Teufel, M., Schäffeler, N., Keim, U., Garbe, C., Eigentler, T., Zipfel, S., & Forschner, A. (2017) · Medicine · doi:10.1097/md.0000000000007987 · Cited by 20 · see citing works
Screening for distress: a role for oncology nursing
Fitch, M. I. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834791a1 · Cited by 17 · see citing works
Physical and psychosocial support requirements of 1,500 patients starting radiotherapy
Kirchheiner, K., Czajka, A., Ponocny‐Seliger, E., Lütgendorf‐Caucig, C., Schmid, M. P., Komarek, E., Pötter, R., & Dörr, W. (2013) · Strahlentherapie und Onkologie · doi:10.1007/s00066-013-0329-y · Cited by 17 · see citing works
First day of radiotherapy for women with breast cancer: predictors of anxiety
Grilo, A. M., Gomes, A. I., Monsanto, F., Albino, D., Augusto, C., & Pragana, C. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04902-1 · Cited by 12 · see citing works
Loth, F. L. C., Meraner, V., Holzner, B., Singer, S., Virgolini, I. J., & Gamper, E. (2018) · Psycho-Oncology · doi:10.1002/pon.4675 · Cited by 10 · see citing works
Self-citationMessage-Based Patient Guidance in Day-Hospital
Lamber, P., Ludwig, B., Ricci⋆, F., et al. (2011) · Proceedings/IEEE International Conference on Mobile Data Management · doi:10.1109/mdm.2011.77 · Cited by 8 · see citing works
“The MobiDay server asks ONCONET for the patients workflow state, and consequently decides what type of message to post.”
MethodDeshpande, A. J., Bhandarkar, A. R., Bobo, W. V., Bydon, M., Niazi, S. K., & McLaughlin, S. A. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.12.019 · Cited by 8 · see citing works
O’Hea, E., Cutillo, A., Dietzen, L. L., Harralson, T. L., Grissom, G. R., Person, S. D., & Boudreaux, E. D. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.02.001 · Cited by 8 · see citing works
“Researchers have studied interventions that reduce such negative effects [2, 3, 4], with recent studies focusing on telephone [5, 6, 7] and computer based interventions [8, 9, 10].”
Zhou, Z., Yuan, J., Zhang, Y., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06610-z · Cited by 4 · see citing works
“Early clinical assessment of social support, especially psychological fatigue surveillance, in breast cancer patients facilitates the provision of more comprehensive care and support [11, 12].”
InfluentialScreening for Distress in Breast Cancer
Mitchell, A. J. (2014) · Current Breast Cancer Reports · doi:10.1007/s12609-014-0157-9 · Cited by 4 · see citing works
Surveying patients with smart devices
Lamber, P., Mitterer, M., Napolitano, L., Ricci⋆, F., & Zini, F. (2012) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2012.6266349 · Cited by 3 · see citing works
Mikoshiba, N., Yamamoto‐Mitani, N., Ohki, T., Asaoka, Y., Yamaguchi, H., Obi, S., Sato, K., Koike, K., & Miyashita, M. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyw112 · Cited by 3 · see citing works
Patient-Reported Outcome Monitoring in Brain Tumour Patients: Benefits and Requirements
Lisa, M., Johannes, M. G., & Holzner, B. (2011) · InTech eBooks · doi:10.5772/22329 · Cited by 2 · see citing works
“Approximately 20-40 percent of cancer patients suffer from psychosocial distress and are therefore in need for referral to psychooncological treatment (Meraner et al., 2009).”
BackgroundSelf-citationNgune, I., Jiwa, M., McManus, A., Parsons, R. W., & Hodder, R. J. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12340 · Cited by 2 · see citing works
Thanasansomboon, B., Choemprayong, S., Parinyanitikul, N., Tanlamai, U., Wisessathorn, M., & Patarapongsant, Y. (2022) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2022.06.002 · Cited by 1 · see citing works
“Therefore, early and effective observation of MBC patients’ psychosocial state during a routine clinical practice is essential to provide sufficient and appropriate support [14].”
BackgroundCortina, C. S., & Kong, A. L. (2023) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2023.01.015 · Cited by 1 · see citing works
An Evaluation of the Influence of Perceptions of Breast Cancer on Distress in Irish Women
Gibbons, A. (2013) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/15855 · Cited by 1 · see citing works
Distress about Caregiver Proximity and Availability: Self-Reports from Breast Cancer Survivors
Crosthwaite, K. (2013) · The Knowledge Bank (The Ohio State University)
- Authors
- Meraner, V., Giesinger, J., Kemmler, G., Taucher, S., Hubalek, M., Weber, B., Rumpold, G., Sperner‐Unterweger, B., & Holzner, B.
- Affiliations
- Innsbruck Medical University (AT)
- Universität Innsbruck (AT)
- Corresponding author
- Holzner, Bernhard
- ORCID
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2009-01-13
- Volume
- 18
- Issue
- 9
- Pages
- 974-983
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W2009690943
- Cited by
- 29
- References
- 49
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 5 · 2012: 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Psycho-Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- breast cancer, screening tool, psychosocial distress, EORTC QLQ-C30, emotional functioning, role functioning, computerized screening, referral to mental health professionals, psychosocial support
- MeSH terms
- Adaptation, Psychological, Adult, Aged, Anxiety, Breast Neoplasms, Depression, Diagnosis, Computer-Assisted, Female, Humans, Mass Screening, Middle Aged, Neoplasm Staging, Patient Acceptance of Health Care, Pilot Projects, Psychometrics, Psychotherapy, Quality of Life, Surveys and Questionnaires, Sick Role, Software, Reproducibility of Results, Needs Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review